Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Accumulated Expenses (2018 - 2019)

Historic Other Accumulated Expenses for Arcturus Therapeutics Holdings (ARCT) over the last 2 years, with Q3 2019 value amounting to $560000.0.

  • Arcturus Therapeutics Holdings' Other Accumulated Expenses changed N/A to $560000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $560000.0, marking a year-over-year change of. This contributed to the annual value of $674000.0 for FY2018, which is N/A changed from last year.
  • Latest data reveals that Arcturus Therapeutics Holdings reported Other Accumulated Expenses of $560000.0 as of Q3 2019.
  • Arcturus Therapeutics Holdings' 5-year Other Accumulated Expenses high stood at $1.3 million for Q2 2019, and its period low was $560000.0 during Q3 2019.